{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:33:10Z","timestamp":1780540390405,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.drugalcdep.2014.04.005","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T02:16:15Z","timestamp":1398305775000},"page":"118-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine\u2013naloxone and standard medical management?"],"prefix":"10.1016","volume":"140","author":[{"given":"Roger D.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Sharpe","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian R.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Dreifuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary S.","family":"Connery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of \u03bc-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study","volume":"65","author":"Anton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsat.2010.05.004","article-title":"Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians","volume":"39","author":"Arfken","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0740-5472(01)00182-9","article-title":"Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings","volume":"21","author":"Brady","year":"2001","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1360-0443.1998.931738.x","article-title":"A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction","volume":"93","author":"Brewer","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00005053-199302000-00001","article-title":"One-year follow-up status of treatment-seeking cocaine abusers: psychopathology and dependence severity as predictors of outcome","volume":"181","author":"Carroll","year":"1993","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1369-1600.2012.00442.x","article-title":"Association of \u03bc-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis","volume":"17","author":"Chamorro","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archpsyc.56.6.493","article-title":"Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse collaborative cocaine treatment study","volume":"56","author":"Crits-Christoph","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1037\/a0029572","article-title":"A comparison of four telephone-based counseling styles for recovering stimulant users","volume":"27","author":"Farabee","year":"2013","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10550880903183042","article-title":"High dose versus moderate dose methadone maintenance: is there a better outcome?","volume":"28","author":"Fareed","year":"2009","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0740-5472(96)00109-2","article-title":"More is better: counseling participation and the effectiveness of outpatient drug treatment","volume":"13","author":"Fiorentine","year":"1996","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1037\/a0026361","article-title":"Attendance and substance use outcomes for the Seeking Safety program: sometimes less is more","volume":"80","author":"Hien","year":"2012","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0060","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0740-5472(97)00308-5","article-title":"Comparative treatment effectiveness: effects of program modality and client drug dependence history on drug use reduction","volume":"15","author":"Hser","year":"1998","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2010.10050755","article-title":"Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking","volume":"168","author":"Johnson","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0070","series-title":"Monitoring the Future National Results on Drug Use: 2012 Overview, Key Findings on Adolescent Drug Use","author":"Johnston","year":"2013"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00002508-200409000-00005","article-title":"Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain","volume":"20","author":"Keller","year":"2004","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1176\/appi.ajp.2013.13081014","article-title":"Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism","volume":"171","author":"Kranzler","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.drugalcdep.2011.03.030","article-title":"Understanding subtypes of inner-city drug users with a latent class approach","volume":"118","author":"Kuramoto","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1360-0443.2008.02147.x","article-title":"Predictors of 4-year outcome of community residential treatment for patients with substance use disorders","volume":"103","author":"Laffaye","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/10826084.2011.521371","article-title":"Connecting to young adults: an online social network survey of beliefs and attitudes associated with prescription opioid misuse among college students","volume":"46","author":"Lord","year":"2011","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1037\/a0019943","article-title":"Clinical outcomes of an integrated treatment for depression and substance use disorders","volume":"24","author":"Lydecker","year":"2010","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1081\/ADA-120002976","article-title":"Evaluation of full vs. partial continuum of care in the treatment of publicly funded substance abusers in Washington State","volume":"28","author":"McKay","year":"2002","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10550490500528316","article-title":"The Addiction Severity Index at 25: origins, contributions and transitions","volume":"15","author":"McLellan","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the Addiction Severity Index reliability and validity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jsat.2005.01.004","article-title":"Influence of psychotherapy attendance on buprenorphine treatment outcome","volume":"28","author":"Montoya","year":"2005","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients","volume":"22","author":"Moore","year":"2007","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1023\/A:1024496427434","article-title":"\u201cSeeking safety\u201d: outcome of a new cognitive-behavioral psychotherapy for women with posttraumatic stress disorder and substance dependence","volume":"11","author":"Najavits","year":"1998","journal-title":"J. Trauma. Stress"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/ADM.0b013e318277e92e","article-title":"A comparison of buprenorphine taper outcomes between prescription opioid and heroin users","volume":"7","author":"Nielsen","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0140","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1530-0277.2008.00698.x","article-title":"A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention","volume":"32","author":"Oslin","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0733464810382906","article-title":"Treatment outcomes for older adults who abuse substances","volume":"31","author":"Outlaw","year":"2012","journal-title":"J. Appl. Gerontol."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.15288\/jsad.2013.74.605","article-title":"Buprenorphine\/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from Starting Treatment with Agonist Replacement Therapies (START)","volume":"74","author":"Potter","year":"2013","journal-title":"J. Stud. Alcohol Drugs"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/10550490701862902","article-title":"Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities","volume":"17","author":"Potter","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0160","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.289.18.2370","article-title":"Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities","volume":"289","author":"Rosenblum","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0165","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMoa1005987","article-title":"Long-acting risperidone and oral antipsychotics in unstable schizophrenia","volume":"364","author":"Rosenheck","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0170","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1360-0443.1996.918119711.x","article-title":"Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome","volume":"91","author":"Saxon","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10550490600625624","article-title":"Characterizing the emerging population of prescription opioid abusers","volume":"15","author":"Sigmon","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0180","series-title":"Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658","author":"Substance Abuse and Mental Health Services Administration","year":"2011"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0185","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1360-0443.2006.01717.x","article-title":"Treatment setting and baseline substance use severity interact to predict patients\u2019 outcomes","volume":"102","author":"Tiet","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2003.08.007","article-title":"Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment","volume":"73","author":"Trafton","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0195","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine\u2013naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cct.2010.01.003","article-title":"A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology","volume":"31","author":"Weiss","year":"2010","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0205","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1037\/a0029418","article-title":"Moderators and non-specific predictors of treatment outcome for anxiety disorders: a comparison of cognitive behavioral therapy to acceptance and commitment therapy","volume":"80","author":"Wolitzky-Taylor","year":"2012","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/SAR.S18969","article-title":"Differences in onset and abuse\/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"2011","author":"Wu","year":"2011","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.drugalcdep.2014.04.005_bib0215","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1530-0277.2008.00743.x","article-title":"Relationship between medication adherence and treatment outcomes: the COMBINE study","volume":"32","author":"Zweben","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161400831X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161400831X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T18:28:15Z","timestamp":1538677695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161400831X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":43,"alternative-id":["S037687161400831X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.04.005","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine\u2013naloxone and standard medical management?","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}